1. Braverman IM: Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 93:2S-9S, 1989
2. Braverman IM, Yen A: Ultrastructure of the human dermal microcirculation. II. The capillary loops of the dermal papillae. J Invest Dermatol 68:44-52, 1977
3. Yen A, Braverman IM: Ultrastructure of the human dermal microcirculation: The horizontal plexus of the papillary dermis. J Invest Dermatol 66:131-142, 1976
4. Remuzzi A et al: Orientation of endothelial cells in shear fields in vitro. Biorheology 21:617-630, 1984
5. Rogers KA, Kalnins, VI: Comparison of the cytoskeleton in aortic endothelial cells in situ and in vitro. Lab Invest 49:650-654, 1983
6. Bradley JR, Pober JS: Prolonged cytokine exposure causes a dynamic redistribution of endothelial cell adhesion molecules to intercellular junctions. Lab Invest 75:463-472, 1996
7. Bonfanti R et al: PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73:1109-1112, 1989
8. Vischer UM, Wagner DD: CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184-1191, 1993
9. Schnyder-Candrian S et al: Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci USA 97:8369-8374, 2000
10. Wolff B et al: Endothelial cell “memory” of inflammatory stimulation: Human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med 188:1757-1762, 1998
11. Fiedler U et al: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235-239, 2006
12. Wisse E et al: Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 24:100-111, 1996
13. Sbaa E et al: The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: A paradox solved through the study of angiogenesis. Trends in Cardiovascular Medicine 15:157-216, 2005
14. Drab M et al: Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452, 2001
15. Pike LJ: Growth factor receptors, lipid rafts and caveolae: An evolving story. Biochim Biophys Acta 1746:260-273, 2005
16. D'Alessio A et al: Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol 166:1273-1282, 2005
17. Chang SH et al: Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol 175:1768-1776, 2009
18. Shivers RR et al: Isolated rat brain capillaries possess intact, structurally complex, interendothelial tight junctions; freeze-fracture verification of tight junction integrity. Brain Res 324:313-322, 1984
19. Bazzoni G: Endothelial tight junctions: Permeable barriers of the vessel wall. Thromb Haemost 95:36-42, 2006
20. Matsumura T et al: Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158:3408-3416, 1997
21. Vittet D et al: Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci USA 94:6273-6278, 1997
22. Baumer S et al: Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107:4754-4762, 2006
23. Grinnell KL et al: Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol L361-L370, 2009
24. Groger M et al: Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 4:e5391, 2009
25. Dejana E et al: The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115-2122, 2008
26. Rudini N et al: VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J 27:993-1004, 2008
27. Beckers CM et al: Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103:40-55, 2010
28. Gavard J et al: Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14:25-36, 2008
29. Winderlich M et al: VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 185:657-671, 2009
30. Grant DS et al: Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 153:614-625, 1992
31. O'Reilly MS et al: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285, 1997
32. Miyamoto S et al: Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 131:791-805, 1995
33. Detmar M: Tumor angiogenesis. J Investig Dermatol Symp Proc 5:20-23, 2000
34. Petzelbauer P et al: Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 151:5062-5072, 1993
35. Febbraio M et al: CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791, 2001
36. Niemela H et al: Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood 106:3405-3409, 2005
37. Groger M et al: IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. Journal of Immunology 173:7161, 2004
38. Groger M et al: A previously unknown dermal blood vessel phenotype in skin inflammation. J Invest Dermatol 127:2893, 2007
39. Kaipainen A et al: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566, 1995
40. Hirakawa S et al: Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162:575, 2003
41. Kriehuber E et al: Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 194:797, 2001
42. Hong YK et al: VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. Faseb J 18:1111, 2004
43. Yuan L et al: Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129:4797, 2002
44. Groger M et al: Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol 156:1549-1556, 1996
45. Vora M et al: Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J Immunol 152:5734-5741, 1994
46. Mitchell JA et al: Role of pattern-recognition receptors in cardiovascular health and disease. Biochem Soc Trans 35:1449, 2007
47. Dauphinee SM, Karsan A: Lipopolysaccharide signaling in endothelial cells. Lab Invest 86:9-22, 2006
48. Faure E et al: Bacterial lipopolysaccharide activates NF-kappa B through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275:11058-11063, 2000
49. Grote K et al: Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration. Blood 115(12):2543-2552, 2010
50. Jimenez R et al: Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci U S A 102:4637, 2005
51. Cartwright N et al: Elucidation of toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli. Shock 27:40, 2007
52. Newby
AC, Henderson AH: Stimulus-secretion coupling in vascular endothelial cells.
Annu Rev Physiol 52:661-674, 1990
53. Rosenkranz-Weiss P et al: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236, 1994
54. Pober JS, Cotran RS: Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol 50:261-302, 1991
55. Lawrence MB et al: Neutrophil tethering to and rolling on E-selectin are separable by requirement for L-selectin. Immunity 1:137-145, 1994
56. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990
57. Johnson P et al: A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochemical Pharmacology 59:455, 2000
58. Banerji S et al: LYVE-1, a New Homologue of the CD44 Glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789, 1999
59. Jackson DG: Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev 230:216, 2009
60. Lechleitner S et al: Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J Exp Med 187:1998
61. Albelda SM et al: Adhesion molecules and inflammatory injury. Faseb J 8:504-512, 1994
62. Hasstedt SJ et al: Cell adhesion molecule 1: A novel risk factor for venous thrombosis. Blood 114:3084, 2009
63. Matsukawa A et al: Chemokines and innate immunity. Rev Immunogenet 2:339-358, 2000
64. Umehara H et al: Fractalkine and vascular injury. Trends Immunol 22:602-607, 2001
65. Yoshie O et al: Chemokines in immunity. Adv Immunol 78:57-110, 2001
66. Mamdouh Z et al: Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J Exp Med 206:2795, 2009
67. Alcaide P et al: p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood 112:2770, 2008
68. Petzelbauer P et al: The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11:298-304, 2005
69. Madri JA et al: The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol 74:749-757, 1996
70. Manes TD, Pober JS: Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells. J Immunol 180:8386, 2008
71. Bach FH et al: Accommodation of vascularized xenografts: expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3:196-204, 1997
72. Collins T et al: Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81:4917-4921, 1984
73. Choi J et al: T lymphocyte-endothelial cell interactions. Annu Rev Immunol 22:683-709, 2004
74. Page C et al: Antigenic heterogeneity of vascular endothelium. Am J Pathol 141:673-683, 1992
75. Amatschek S et al: Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood 109:4777, 2007
76. Pober JS et al: Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 61:343-349, 1996
77. Shiao SL et al: Memory T cells and their costimulators in human allograft injury. J Immunol 175:4886, 2005
78. Suarez Y et al: Alloimmunity to human endothelial cells derived from cord blood progenitors. J Immunol 179:7488, 2007
79. Khayyamian S et al: ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci USA 99:6198, 2002
80. Krupnick AS et al: Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol 175:6265-6270, 2005
81. Kebir H et al: Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173, 2007
82. Huppert J et al: Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24(4):1023-1034, 2010; [Epub 2009]
83. Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 21:467, 2004
84. Oble DA et al: Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 9:3, 2009
85. Corthay A: How do regulatory T cells work? Scand J Immunol 70:326, 2009
86. Nummer D et al: Role of tumor endothelium in CD4+CD25+ regulatory t cell infiltration of human pancreatic carcinoma. J Natl Cancer Inst 99:1188-1199, 2007
87. Austrup F et al: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81-83, 1997
88. Hirata T et al: P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J Exp Med 192:1669-1676, 2000
89. Das PK et al: Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm Venereol Suppl (Stockh) 186:21-22, 1994
90. Petzelbauer P et al: Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 103:300-305, 1994
91. Schechner JS et al: Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis. Lab Invest 79:601-607, 1999
92. Berg EL et al: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 174:1461-1466, 1991
93. Picker LJ et al: A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 136:1053-1068, 1990
94. Fuhlbrigge RC et al: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
95. Kunstfeld R et al: HECA-452+ T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. J Invest Dermatol 108:343-348, 1997
96. Leung DY et al: Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 87:1805-1809, 1991
97. Lechleitner S et al: Peripheral lymph node addressins are expressed on skin endothelial cells. J Invest Dermatol 113:410-414, 1999
98. Hamann A et al: Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 152:3282-3293, 1994
99. Pober JS et al: Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann N Y Acad Sci 941:12-25, 2001
100. Furuta C et al: Discordant developmental waves of angioblasts and hemangioblasts in the early gastrulating mouse embryo. Development 133:2771-2779, 2006
101. Risau W, Flamme I: Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91, 1995
102. Asahara T et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
103. Ribatti D et al: Endothelial progenitor cells in health and disease. Histol Histopathol 20:1351-1358, 2005
104. Lyden D et al: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194, 2001
105. Rafii S, Lyden D: Cancer. A few to flip the angiogenic switch. Science 319:163, 2008
106. Gao D et al: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319:195, 2008
107. Yancopoulos GD et al: Vascular-specific growth factors and blood vessel formation. Nature 407:242-248, 2000
108. Alessandri G et al: Human vasculogenesis ex vivo: Embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 81:875, 2001
109. Pacilli A, Pasquinelli G: Vascular wall resident progenitor cells: A review. Experimental Cell Research 315:901, 2009
110. Karkkainen MJ et al: A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98:12677-12682, 2001
111. Makinen T et al: Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7:199-205, 2001
112. Fernig DG, Gallagher JT: Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353-377, 1994
113. Gospodarowicz D et al: Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and
thrombin.
J Cell Biol 77:774-788, 1978
114. Ushiro S et al: Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells. Jpn J Cancer Res 87:68-77, 1996
115. Grant DS et al: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941, 1993
116. Maisonpierre PC et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
117. Jones N et al: Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2:438-445, 2001
118. Adachi H et al: Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem 272:31217-31220, 1997
119. Gale NW et al: Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230:151-160, 2001
120. Janzer RC, Raff MC: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325:253-257, 1987
121. McAllister KA et al: Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351, 1994
122. Beck L, Jr., D'Amore, PA: Vascular development: cellular and molecular regulation. Faseb J 11:365-373, 1997
123. Carmeliet P et al: Role of tissue factor in embryonic blood vessel development. Nature 383:73-75, 1996
124. Brown LF et al: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379, 1992
125. Detmar M et al: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108:263-268, 1997
126. Lichtenberger BM et al: Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 140:268, 2010
127. Detmar M et al: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50, 1995
128. Broadley KN et al: Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 61:571-575, 1989
129. Christofidou-Solomidou M et al: Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am J Pathol 151:975-983, 1997
130. Reynolds LE et al: Accelerated re-epithelialization in beta3-integrin-deficient-mice is associated with enhanced TGF-beta1 signaling. Nat Med 11:167-174, 2005
131. Leek RD et al: Cytokine networks in solid human tumors: Regulation of angiogenesis. J Leukoc Biol 56:423-435, 1994
132. Naidu YM et al: Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci USA 91:5281-5285, 1994
133. Braverman IM, Sibley J: Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 78:12-17, 1982
134. Brody I: Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 82:465-470, 1984
135. Detmar M et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146, 1994
136. Lange-Asschenfeldt B et al: Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2–deficient mice. Blood 99:538-545, 2002
137. Eming SA et al: Regulation of angiogenesis: Wound healing as a model. Progress in Histochemistry and Cytochemistry 42:115, 2007
138. Bao P et al: The role of vascular endothelial growth factor in wound healing. Journal of Surgical Research 153:347, 2009
139. Lerman OZ et al: Cellular dysfunction in the diabetic fibroblast: Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162:303, 2003
140. Liu ZJ, Velazquez OC: Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 10:1869, 2008